Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Positron Emission Tomography Score Has Greater Prognostic Significance Than Pretreatment Risk Stratification in Early-Stage Hodgkin Lymphoma in the UK RAPID Study
Sally F. Barrington, Elizabeth H. Phillips, Nicholas Counsell, et al.
Journal of Clinical Oncology (2019) Vol. 37, Iss. 20, pp. 1732-1741
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Hodgkin lymphoma: 2023 update on diagnosis, risk‐stratification, and management
Stephen M. Ansell
American Journal of Hematology (2022) Vol. 97, Iss. 11, pp. 1478-1488
Closed Access | Times Cited: 67
Classical Hodgkin lymphoma
Pauline Brice, É. de Kerviler, Jonathan W. Friedberg
The Lancet (2021) Vol. 398, Iss. 10310, pp. 1518-1527
Open Access | Times Cited: 58
Risk-adapted modulation through de-intensification of cancer treatments: an ESMO classification
Dario Trapani, Maria Alice Franzoi, Harold J. Burstein, et al.
Annals of Oncology (2022) Vol. 33, Iss. 7, pp. 702-712
Open Access | Times Cited: 41
Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 1—Clinical)
Fabien Ricard, Bruce D. Cheson, Sally F. Barrington, et al.
Journal of Nuclear Medicine (2022) Vol. 64, Iss. 1, pp. 102-108
Open Access | Times Cited: 30
Hodgkin lymphoma: 2025 update on diagnosis, risk‐stratification, and management
Stephen M. Ansell
American Journal of Hematology (2024)
Closed Access | Times Cited: 6
FDG-PET Imaging for Hodgkin and Diffuse Large B-Cell Lymphoma—An Updated Overview
Conrad‐Amadeus Voltin, Jasmin Mettler, Jirka Grosse, et al.
Cancers (2020) Vol. 12, Iss. 3, pp. 601-601
Open Access | Times Cited: 41
Guideline for the first‐line management of Classical Hodgkin Lymphoma — A British Society for Haematology guideline
George Follows, Sally F. Barrington, Kaljit Bhuller, et al.
British Journal of Haematology (2022) Vol. 197, Iss. 5, pp. 558-572
Open Access | Times Cited: 25
Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in elderly HL: a two-center experience in 123 patients
Domenico Albano, Angelica Mazzoletti, Marianna Spallino, et al.
Annals of Hematology (2020) Vol. 99, Iss. 6, pp. 1321-1330
Closed Access | Times Cited: 36
FDG‐PET/CT after two cycles of R‐CHOP in DLBCL predicts complete remission but has limited value in identifying patients with poor outcome – final result of a UK National Cancer Research Institute prospective study
N. George Mikhaeel, David Cunningham, Nicholas Counsell, et al.
British Journal of Haematology (2020) Vol. 192, Iss. 3, pp. 504-513
Open Access | Times Cited: 33
Quantitative FDG PET Assessment for Oncology Therapy
Kenji Hirata, Nagara Tamaki
Cancers (2021) Vol. 13, Iss. 4, pp. 869-869
Open Access | Times Cited: 32
FDG-PET/CT in Lymphoma: Where Do We Go Now?
Yassine Al Tabaa, Clément Bailly, Salim Kanoun
Cancers (2021) Vol. 13, Iss. 20, pp. 5222-5222
Open Access | Times Cited: 29
Maximum Tumor Diameter is Associated with Relapse Risk in Limited-Stage Hodgkin Lymphoma: An International Study
Elizabeth H. Phillips, Nicholas Counsell, Tim Illidge, et al.
Blood Advances (2025)
Open Access
Modified Endothelial Activation and Stress Index: A New Predictor for Survival Outcomes in Classical Hodgkin Lymphoma Treated with Doxorubicin-Bleomycin-Vinblastine-Dacarbazine-Based Therapy
Fazıl Çağrı Hunutlu, Hikmet Öztop, Vildan Gürsoy, et al.
Diagnostics (2025) Vol. 15, Iss. 2, pp. 185-185
Open Access
Positron emission tomography-adapted therapy for first-line treatment in adults with Hodgkin lymphoma
Nina Kreuzberger, Marius Goldkuhle, Bastian von Tresckow, et al.
Cochrane library (2025) Vol. 2025, Iss. 3
Closed Access
The role of PET in first-line treatment of Hodgkin lymphoma
Judith Trotman, Sally F. Barrington
The Lancet Haematology (2020) Vol. 8, Iss. 1, pp. e67-e79
Closed Access | Times Cited: 31
Optimizing outcomes in relapsed/refractory Hodgkin lymphoma: a review of current and forthcoming therapeutic strategies
Theodoros P. Vassilakopoulos, John Asimakopoulos, Kostas Konstantopoulos, et al.
Therapeutic Advances in Hematology (2020) Vol. 11
Open Access | Times Cited: 29
Incorporating Monoclonal Antibodies into the First-Line Treatment of Classical Hodgkin Lymphoma
Theodoros P. Vassilakopoulos, Athanasios Liaskas, Patricio Javier Pereyra, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13187-13187
Open Access | Times Cited: 10
Circulating Tumor DNA Sequencing for Biologic Classification and Individualized Risk Stratification in Patients With Hodgkin Lymphoma
Jan‐Michel Heger, Laman Mammadova, Julia Mattlener, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 35, pp. 4218-4230
Closed Access | Times Cited: 3
Maximum tumor diameter is associated with event-free survival in PET-negative patients with stage I/IIA Hodgkin lymphoma
Tim Illidge, Elizabeth H. Phillips, Nicholas Counsell, et al.
Blood Advances (2020) Vol. 4, Iss. 1, pp. 203-206
Open Access | Times Cited: 21
Current Role of Functional Imaging in the Management of Lymphoma
Bruce D. Cheson, Michel Meignan
Current Oncology Reports (2021) Vol. 23, Iss. 12
Closed Access | Times Cited: 18
Contemporary radiation therapy use in Hodgkin lymphoma
Omran Saifi, Bradford S. Hoppe
Seminars in Hematology (2024) Vol. 61, Iss. 4, pp. 263-269
Closed Access | Times Cited: 2
Machine Learning for Automated Interpretation of Fluorodeoxyglucose-Positron Emission Tomography Scans in Lymphoma
Heiko Schöder
Journal of Clinical Oncology (2024) Vol. 42, Iss. 25, pp. 2945-2948
Closed Access | Times Cited: 2
Positron Emission Tomography Molecular Imaging for Phenotyping and Management of Lymphoma
Xiaohui Zhang, Han Jiang, Shuang Wu, et al.
Phenomics (2022) Vol. 2, Iss. 2, pp. 102-118
Open Access | Times Cited: 11
PET-CT in Clinical Adult Oncology: I. Hematologic Malignancies
Ahmed Ebada Salem, Harsh Shah, Matthew F. Covington, et al.
Cancers (2022) Vol. 14, Iss. 23, pp. 5941-5941
Open Access | Times Cited: 10
Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early-stage Hodgkin’s lymphoma
Marius Goldkuhle, Nina Kreuzberger, Bastian von Tresckow, et al.
Cochrane library (2024) Vol. 2024, Iss. 12
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top